Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1959 Apr 25;1(5129):1081–1083. doi: 10.1136/bmj.1.5129.1081

Treatment of Cardiac Shock by Metaraminol

E M M Besterman
PMCID: PMC1993028  PMID: 13638636

Full text

PDF
1081

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARDHANABAEDYA S., DENISON A. B., Jr, GREEN H. D. Adrenergic drugs and blockade on coronary arterioles and myocardial contraction. Circ Res. 1956 Nov;4(6):653–658. doi: 10.1161/01.res.4.6.653. [DOI] [PubMed] [Google Scholar]
  2. BROFMAN B. L., HELLERSTEIN H. K., CASKEY W. H. Mephentermine: an effective pressor amine; clinical and laboratory observations. Am Heart J. 1952 Sep;44(3):396–406. doi: 10.1016/0002-8703(52)90261-5. [DOI] [PubMed] [Google Scholar]
  3. BURN J. H., HUTCHEON D. E. The action of noradrenaline. Br J Pharmacol Chemother. 1949 Dec;4(4):373–380. doi: 10.1111/j.1476-5381.1949.tb00564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FANKHAUSER A., FISHMAN S. I., MADONIA P. F., SCHWARTZ G., STECHEL G. H., TURKOWITZ H. The use of aramine in clinical shock. Circulation. 1956 Jun;13(6):834–836. doi: 10.1161/01.cir.13.6.834. [DOI] [PubMed] [Google Scholar]
  5. GARAI O., SMITH K. S. Use of pressor agents in shock in myocardial infarction. Br Med J. 1958 Feb 1;1(5065):247–251. doi: 10.1136/bmj.1.5065.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. GAZES P. C., GOLDBERG L. I., DARBY T. D. Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction. Circulation. 1953 Dec;8(6):883–892. doi: 10.1161/01.cir.8.6.883. [DOI] [PubMed] [Google Scholar]
  7. GRIFFITH G. C., WALLACE W. B., COCHRAN B., Jr, NERLICH W. E., FRASHER W. E. The treatment of shock associated with myocardial infarction. Circulation. 1954 Apr;9(4):527–532. doi: 10.1161/01.cir.9.4.527. [DOI] [PubMed] [Google Scholar]
  8. HELLERSTEIN H. K., BROFMAN B. L., CASKEY W. H. Shock accompanying myocardial infarction: treatment with pressor amines amines. Am Heart J. 1952 Sep;44(3):407–427. doi: 10.1016/0002-8703(52)90262-7. [DOI] [PubMed] [Google Scholar]
  9. MOYER J. H., BEAZLEY H. L. Effectiveness of aramine in the treatment of shock. Am Heart J. 1955 Jul;50(1):136–144. doi: 10.1016/0002-8703(55)90259-3. [DOI] [PubMed] [Google Scholar]
  10. MOYER J. H., MORRIS G., SNYDER H., SMITH C. P. A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject. Circulation. 1954 Aug;10(2):265–270. doi: 10.1161/01.cir.10.2.265. [DOI] [PubMed] [Google Scholar]
  11. MOYER J. H., MORRIS G. Vasopressor agents for severe hypotension and shock: with particular emphasis on renal hemodynamic responses. Postgrad Med. 1954 Oct;16(4):287–296. doi: 10.1080/00325481.1954.11711688. [DOI] [PubMed] [Google Scholar]
  12. MOYER J. H., SKELTON J. M., MILLS L. C. Nor-epinephrine; effect in normal subjects; use in treatment of shock unresponsive to other measures. Am J Med. 1953 Sep;15(3):330–343. doi: 10.1016/0002-9343(53)90087-4. [DOI] [PubMed] [Google Scholar]
  13. POE M. F. The use of aramine as a pressor agent during spinal anesthesia. Anesthesiology. 1954 Sep;15(5):547–550. doi: 10.1097/00000542-195409000-00013. [DOI] [PubMed] [Google Scholar]
  14. SAMPSON J. J., ZIPSER A. Norepinephrine in shock following myocardial infarction; influence upon survival rate and renal function. Circulation. 1954 Jan;9(1):38–47. doi: 10.1161/01.cir.9.1.38. [DOI] [PubMed] [Google Scholar]
  15. SARNOFF S. J., CASE R. B., BERGLUND E., SARNOFF L. C. Ventricular function. V. The circulatory effects of aramine; mechanism of action of vasopressor drugs in cardiogenic shock. Circulation. 1954 Jul;10(1):84–93. doi: 10.1161/01.cir.10.1.84. [DOI] [PubMed] [Google Scholar]
  16. WEIL M. H. Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock. Am J Med Sci. 1955 Oct;230(4):357–369. doi: 10.1097/00000441-195510000-00001. [DOI] [PubMed] [Google Scholar]
  17. WELCH G. H., Jr, BRAUNWALD E., CASE R. B., SARNOFF S. J. The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance. Am J Med. 1958 Jun;24(6):871–881. doi: 10.1016/0002-9343(58)90340-1. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES